Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.

Srinivas R Viswanathan | Gavin Ha | Andreas M Hoff | Jeremiah A Wala | Jian Carrot-Zhang | Christopher W Whelan | Nicholas J Haradhvala | Samuel S Freeman | Sarah C Reed | Justin Rhoades | Paz Polak | Michelle Cipicchio | Stephanie A Wankowicz | Alicia Wong | Tushar Kamath | Zhenwei Zhang | Gregory J Gydush | Denisse Rotem | PCF/SU2C International Prostate Cancer Dream Team | J Christopher Love | Gad Getz | Stacey Gabriel | Cheng-Zhong Zhang | Scott M Dehm | Peter S Nelson | Eliezer M Van Allen | Atish D Choudhury | Viktor A Adalsteinsson | Rameen Beroukhim | Mary-Ellen Taplin | Matthew Meyerson
Cell | 2018

Nearly all prostate cancer deaths are from metastatic castration-resistant prostate cancer (mCRPC), but there have been few whole-genome sequencing (WGS) studies of this disease state. We performed linked-read WGS on 23 mCRPC biopsy specimens and analyzed cell-free DNA sequencing data from 86 patients with mCRPC. In addition to frequent rearrangements affecting known prostate cancer genes, we observed complex rearrangements of the AR locus in most cases. Unexpectedly, these rearrangements include highly recurrent tandem duplications involving an upstream enhancer of AR in 70%-87% of cases compared with <2% of primary prostate cancers. A subset of cases displayed AR or MYC enhancer duplication in the context of a genome-wide tandem duplicator phenotype associated with CDK12 inactivation. Our findings highlight the complex genomic structure of mCRPC, nominate alterations that may inform prostate cancer treatment, and suggest that additional recurrent events in the non-coding mCRPC genome remain to be discovered.

Pubmed ID: 29909985

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA188228
  • Agency: NCI NIH HHS, United States
    Id: P50 CA090381
  • Agency: CIHR, Canada
    Id: MFE-140389
  • Agency: NCI NIH HHS, United States
    Id: R01 CA174777
  • Agency: NCI NIH HHS, United States
    Id: P50 CA097186
  • Agency: NCI NIH HHS, United States
    Id: K08 CA188615
  • Agency: NHGRI NIH HHS, United States
    Id: T32 HG002295
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009172
  • Agency: NCI NIH HHS, United States
    Id: R01 CA215489
  • Agency: NCI NIH HHS, United States
    Id: R35 CA197568
  • Agency: NCI NIH HHS, United States
    Id: P01 CA163227

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BWA (tool)

RRID:SCR_010910

Software for aligning sequencing reads against large reference genome. Consists of three algorithms: BWA-backtrack, BWA-SW and BWA-MEM. First for sequence reads up to 100bp, and other two for longer sequences ranged from 70bp to 1Mbp.

View all literature mentions

GenVisR (tool)

RRID:SCR_027559

Software R package for visualizing genomics data. Provides a user-friendly, flexible and comprehensive suite of tools for visualizing complex genomic data in three categories (small variants, copy number alterations and data quality) for multiple species of interest.

View all literature mentions